Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases

NCT00582894 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT00582894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00582894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
Lead sponsor
University of Oklahoma
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2005
Completion date
March 31, 2008
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological neoplasms, hematopoietic stem cell transplantation